AC
AONC

Aristeia Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Aristeia Capital’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-424,642
Closed -$4.27M – 425
2022
Q4 		$4.27M Hold
424,642
– – 0.09% 243
2022
Q3 		$4.17M Buy
424,642
+183,335
+76% +$1.8M 0.07% 312
2022
Q2 		$2.36M Buy
241,307
+55,747
+30% +$545K 0.04% 350
2022
Q1 		$1.81M Buy
+185,560
New +$1.8M 0.03% 364

Other funds holding AONC

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Aristeia Capital's AONC Position: Q1 2023 in Review

Aristeia Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 424,642 shares — an estimated $4.27M sold.

Aristeia Capital first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $4.27M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Aristeia Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Aristeia Capital sold 424,642 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $4.27M.
  • Aristeia Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
  • Aristeia Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $4.27M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.